6XZB
E. coli 70S ribosome in complex with dirithromycin, fMet-Phe-tRNA(Phe) and deacylated tRNA(iMet) (focused classification).
これはPDB形式変換不可エントリーです。
6XZB の概要
| エントリーDOI | 10.2210/pdb6xzb/pdb |
| EMDBエントリー | 10657 |
| 分子名称 | 16S rRNA, 30S ribosomal protein S10, 30S ribosomal protein S11, ... (55 entities in total) |
| 機能のキーワード | 70s ribosome, dirithromycin, antibiotics, cryo-em, ribosome |
| 由来する生物種 | Escherichia coli K-12 詳細 |
| タンパク質・核酸の鎖数 | 54 |
| 化学式量合計 | 2164911.72 |
| 構造登録者 | Pichkur, E.B.,Polikanov, Y.S.,Myasnikov, A.G.,Konevega, A.L. (登録日: 2020-02-03, 公開日: 2020-11-04, 最終更新日: 2025-03-12) |
| 主引用文献 | Pichkur, E.B.,Paleskava, A.,Tereshchenkov, A.G.,Kasatsky, P.,Komarova, E.S.,Shiriaev, D.I.,Bogdanov, A.A.,Dontsova, O.A.,Osterman, I.A.,Sergiev, P.V.,Polikanov, Y.S.,Myasnikov, A.G.,Konevega, A.L. Insights into the improved macrolide inhibitory activity from the high-resolution cryo-EM structure of dirithromycin bound to the E. coli 70S ribosome. Rna, 26:715-723, 2020 Cited by PubMed Abstract: Macrolides are one of the most successful and widely used classes of antibacterials, which kill or stop the growth of pathogenic bacteria by binding near the active site of the ribosome and interfering with protein synthesis. Dirithromycin is a derivative of the prototype macrolide erythromycin with additional hydrophobic side chain. In our recent study, we have discovered that the side chain of dirithromycin forms lone pair-π stacking interaction with the aromatic imidazole ring of the His69 residue in ribosomal protein uL4 of the 70S ribosome. In the current work, we found that neither the presence of the side chain, nor the additional contact with the ribosome, improve the binding affinity of dirithromycin to the ribosome. Nevertheless, we found that dirithromycin is a more potent inhibitor of in vitro protein synthesis in comparison with its parent compound, erythromycin. Using high-resolution cryo-electron microscopy, we determined the structure of the dirithromycin bound to the translating 70S ribosome, which suggests that the better inhibitory properties of the drug could be rationalized by the side chain of dirithromycin pointing into the lumen of the nascent peptide exit tunnel, where it can interfere with the normal passage of the growing polypeptide chain. PubMed: 32144191DOI: 10.1261/rna.073817.119 主引用文献が同じPDBエントリー |
| 実験手法 | ELECTRON MICROSCOPY (2.54 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






